Condition

Advanced Solid Cancer clinical trials and research

• 8Clinical trials
• 5Countries

Newest Advanced Solid Cancer clinical trials

All recruiting trials (8)

• SIM0613 in people with advanced solid tumors

  A first-in-human, multicenter study testing SIM0613 to see if it is safe and tolerable and whether it has any effect in adults with advanced solid cancers.

  Recruiting Phase 1 Jiangsu Simcere Pharmaceutical Co., Ltd. · Tianjin, Tianjin Municipality · NCT07618260

• Testing how well different doses of BI 3819026 can be tolerated alone and with ezabenlimab in advanced cancer

  This study tests whether varying doses of BI 3819026 can be tolerated by adults with advanced solid cancers, both by itself and in combination with ezabenlimab.

  Recruiting at 8 sites Phase 1 Boehringer Ingelheim · New Haven, Connecticut and 8 other locations · NCT07607678

• Phase I testing of SIM0609 in adults with advanced or metastatic solid tumors

  This trial tests SIM0609 to see if it is safe, tolerated, and can shrink tumors in adults with locally advanced or metastatic solid tumors who have exhausted standard treatments.

  Recruiting Phase 1 Jiangsu Simcere Pharmaceutical Co., Ltd. · Beijing and 5 other locations · NCT07265921

• Personalized KXV01 TCR Lentinvivo Injection for Advanced Solid Tumors

  A first-in-human, single-arm study tests a KXV01 TCR lentiviral treatment given in vivo to see if it is safe and tolerable for adults with advanced solid cancers that have exhausted standard therapies.

  Recruiting Phase 1 TCRx Therapeutics Co.Ltd · Hefei, Anhui · NCT07196579

• APX-343A alone or with pembrolizumab for advanced solid tumors

  This Phase 1 trial will test whether APX-343A by itself or combined with the immunotherapy pembrolizumab is safe and shows early benefit in adults with advanced solid tumors.

  Recruiting at 3 sites Phase 1 Aptabio Therapeutics, Inc. · Seongnam and 2 other locations · NCT07123415

• MHB046C injection for adults with advanced solid tumors

  This study will test whether MHB046C injections are safe and might shrink or control advanced solid tumors in adults who have no standard treatment options.

  Recruiting Phase 1/2 Minghui Pharmaceutical (Hangzhou) Ltd · Guangzhou, Guangdong · NCT06985355

• SYN818 for advanced or metastatic solid tumors

  This Phase 1 study will test oral SYN818 in adults with advanced or metastatic solid tumors, including breast, ovarian, and prostate cancers, whose standard treatments have been exhausted.

  Recruiting at 2 sites Phase 1 Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd · Zhengzhou, Henan and 1 other locations · NCT06666270

• APG-2449 for advanced solid tumors

  This study is testing a new oral medication called APG-2449 to see how well it works and what the safe dosage is for people with advanced solid tumors like non-small cell lung cancer.

  Recruiting at 7 sites Phase 1 Ascentage Pharma Group Inc. · Beijing, Beijing Municipality and 8 other locations · NCT03917043

Related topics

Quick answers

How many Advanced Solid Cancer clinical trials are recruiting right now?

8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 5 countries. The most sites are in China (6 trials), Japan (1 trial), Spain (1 trial), United States (1 trial), South Korea (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 7, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →